Brinker Capital’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$4.42M Buy
134,878
+20,056
+17% +$640K 0.14% 160
2020
Q1
$3.46M Sell
114,822
-141,548
-55% -$4.21M 0.14% 159
2019
Q4
$7.42M Sell
256,370
-76,046
-23% -$2.11M 0.23% 96
2019
Q3
$8.59M Buy
332,416
+27,484
+9% +$695K 0.29% 71
2019
Q2
$7.78M Buy
304,932
+1,488
+0.5% +$36.8K 0.28% 76
2019
Q1
$7.94M Sell
303,444
-106,500
-26% -$2.62M 0.3% 67
2018
Q4
$9.44M Sell
409,944
-17,402
-4% -$387K 0.42% 46
2018
Q3
$10.1M Sell
427,346
-4,718
-1% -$115K 0.36% 49
2018
Q2
$9.96M Sell
432,064
-5,406
-1% -$128K 0.38% 45
2018
Q1
$10.8M Buy
437,470
+5,952
+1% +$156K 0.42% 35
2017
Q4
$11.6M Sell
431,518
-3,484
-0.8% -$88.6K 0.45% 30
2017
Q3
$10.5M Buy
435,002
+96,032
+28% +$2.17M 0.43% 31
2017
Q2
$7.27M Buy
338,970
+1,940
+0.6% +$39.1K 0.34% 59
2017
Q1
$5.8M Buy
337,030
+89,468
+36% +$1.56M 0.27% 71
2016
Q4
$4.44M Buy
+247,562
New +$4.49M 0.25% 91
2016
Q3
Sell
-11,490
Closed -$309K 296
2016
Q2
$309K Buy
11,490
+3,240
+39% +$88.9K 0.03% 224
2016
Q1
$223K Buy
+8,250
New +$221K 0.02% 234

Other funds holding NVO

Brinker Capital's NVO Position: Q2 2020 in Review

Brinker Capital increased its Novo Nordisk (NVO) stake by 17% in Q2 2020, buying an estimated $640K and bringing the position to 134,878 shares worth $4.42M. The position accounts for 0.14% of the portfolio, ranked #160.

Brinker Capital first reported a position in NVO in Q1 2016 and has held it in 17 quarters since. The position peaked at $11.6M in Q4 2017. 661 funds tracked by Wall St. Rank hold NVO as of Q2 2020.

  • Brinker Capital held 134,878 shares of Novo Nordisk worth $4.42M as of Q2 2020.
  • Brinker Capital bought 20,056 Novo Nordisk shares in Q2 2020, an estimated $640K.
  • Novo Nordisk made up 0.14% of Brinker Capital's portfolio in Q2 2020, its #160 holding.
  • Brinker Capital first reported a position in Novo Nordisk in Q1 2016 and has held it in 17 quarters since.
  • Brinker Capital's Novo Nordisk position peaked at $11.6M in Q4 2017.
  • 661 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.